Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Non-compliant with Nasdaq Listing Rule

NEW YORK (GenomeWeb News) – Accelrys said on Friday that it has been notified by Nasdaq that the company does not comply with a listing requirement that its audit committee be comprised of three independent directors.

The San Diego-based firm received written notification from Nasdaq on June 4, Accelrys said in a document filed with the US Securities and Exchange Commission. The non-compliance results from Kenneth Coleman's decision not to seek re-election to the company's board for personal reasons. Coleman is a member of Accelrys' audit committee and his decision leaves the firm short of Nasdaq's three-person requirement.

Accelrys has until the company's next shareholder meeting on May 30, 2014 to provide evidence to Nasdaq that it fulfills the listing requirement. If the shareholder meeting is held before Nov. 26, 2013, Accelrys has until that date to provide its evidence, though Accelrys said it doesn't have plans to hold its shareholder meeting before Nov. 26.

It is currently identifying candidates to replace Coleman, Accelrys said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.